These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4017166)

  • 1. Nephrotoxicity of lomustine. A case report and literature review.
    Ellis ME; Weiss RB; Kuperminc M
    Cancer Chemother Pharmacol; 1985; 15(2):174-5. PubMed ID: 4017166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary fibrosis associated with lomustine (CCNU): a case report.
    Vats TS; Trueworthy RC; Langston CM
    Cancer Treat Rep; 1982 Oct; 66(10):1881-2. PubMed ID: 7127329
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrotoxicity of nitrosoureas.
    Schacht RG; Feiner HD; Gallo GR; Lieberman A; Baldwin DS
    Cancer; 1981 Sep; 48(6):1328-34. PubMed ID: 7272960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats.
    Bethune CR; Geyer RJ; Spence AM; Ho RJ
    Cancer Res; 2001 May; 61(9):3669-74. PubMed ID: 11325837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiorgan failure associated with lomustine overdose.
    Trent KC; Myers L; Moreb J
    Ann Pharmacother; 1995 Apr; 29(4):384-6. PubMed ID: 7633017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lipid association on lomustine (CCNU) administered intracerebrally to syngeneic 36B-10 rat brain tumors.
    Yimam MA; Bui T; Ho RJ
    Cancer Lett; 2006 Dec; 244(2):211-9. PubMed ID: 16455196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitivity in childhood brain tumours in vitro: evidence of differential sensitivity to lomustine (CCNU) and vincristine.
    Lewandowicz GM; Harding B; Harkness W; Hayward R; Thomas DG; Darling JL
    Eur J Cancer; 2000 Oct; 36(15):1955-64. PubMed ID: 11000577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of malignant gliomas: comparison of the effect of polychemo- and CCNU-therapy.
    Heiss WD
    Acta Neurochir (Wien); 1978; 42(1-2):109-15. PubMed ID: 696439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
    Finlay JL; Boyett JM; Yates AJ; Wisoff JH; Milstein JM; Geyer JR; Bertolone SJ; McGuire P; Cherlow JM; Tefft M
    J Clin Oncol; 1995 Jan; 13(1):112-23. PubMed ID: 7799011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-agent chemotherapy of brain tumors. A five-year review.
    Wilson CB; Gutin P; Boldrey EB; Drafts D; Levin VA; Enot KJ
    Arch Neurol; 1976 Nov; 33(11):739-44. PubMed ID: 185991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled study of CCNU and radiation therapy in malignant astrocytoma.
    Reagan TJ; Bisel HF; Childs DS; Layton DD; Rhoton AL; Taylor WF
    J Neurosurg; 1976 Feb; 44(2):186-90. PubMed ID: 173814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progressive insufficiency after CCNU therapy].
    Berglund J
    Lakartidningen; 1980 Apr; 77(18):1760. PubMed ID: 7382694
    [No Abstract]   [Full Text] [Related]  

  • 13. Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors.
    Brufman G; Halpern J; Sulkes A; Catane R; Biran S
    Oncology; 1984; 41(4):239-41. PubMed ID: 6462602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
    Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas.
    Kim L; Hochberg FH; Thornton AF; Harsh GR; Patel H; Finkelstein D; Louis DN
    J Neurosurg; 1996 Oct; 85(4):602-7. PubMed ID: 8814163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy and CCNU in the treatment of high-grade supratentorial astrocytomas.
    Weir B; Band P; Urtasun R; Blain G; Mclean D; Wilson F; Mielke B; Grace M
    J Neurosurg; 1976 Aug; 45(2):129-34. PubMed ID: 939970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia.
    Cordonnier C; Vernant JP; Mital P; Lange F; Bernaudin JF; Rochant H
    Cancer; 1983 May; 51(10):1814-8. PubMed ID: 6572542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy combined with procarbazine, bleomycin, and CCNU in the treatment of high-grade supratentorial astrocytomas.
    Seiler RW; Greiner RH; Zimmerman A; Markwalder H
    J Neurosurg; 1978 Jun; 48(6):861-5. PubMed ID: 77898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Hodgkin's disease in a patient receiving procarbazine, CCNU, and vincristine therapy for a gemistocytic astrocytoma.
    Crafts DC; Townsend J; Wilson CB; Levin VA
    Cancer Treat Rep; 1978 Jan; 62(1):177-8. PubMed ID: 626997
    [No Abstract]   [Full Text] [Related]  

  • 20. Salvage therapy with lomustine for temozolomide refractory recurrent anaplastic astrocytoma: a retrospective study.
    Chamberlain MC
    J Neurooncol; 2015 Apr; 122(2):329-38. PubMed ID: 25563816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.